Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

In young children, persistent wheezing is associated with bronchial bacterial infection: a retrospective analysis.

De Schutter I, Dreesman A, Soetens O, De Waele M, Crokaert F, Verhaegen J, Piérard D, Malfroot A.

BMC Pediatr. 2012 Jun 22;12:83. doi: 10.1186/1471-2431-12-83.

2.

Prospective evaluation of Coris Influ-A&B Respi-Strip and of BinaxNOW Influenza A&B assay against viral culture and real-time PCR assay for detection of 2009 pandemic influenza A/H1N1v in Belgian patients.

Reynders M, De Foor M, Maaroufi Y, Thomas I, Vergison A, Debulpaep S, Vandenberg O, Crokaert F.

Acta Clin Belg. 2012 Mar-Apr;67(2):94-8.

PMID:
22712164
3.

Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen.

De Schutter I, De Wachter E, Crokaert F, Verhaegen J, Soetens O, Piérard D, Malfroot A.

Clin Infect Dis. 2011 Jun 15;52(12):1437-44. doi: 10.1093/cid/cir235.

PMID:
21628484
4.

Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation.

Ahmad I, Cau NV, Kwan J, Maaroufi Y, Meuleman N, Aoun M, Lewalle P, Martiat P, Crokaert F, Bron D.

Transplantation. 2009 Apr 27;87(8):1240-5. doi: 10.1097/TP.0b013e31819f1c49.

PMID:
19384173
5.

Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study.

Meuleman N, Tondreau T, Ahmad I, Kwan J, Crokaert F, Delforge A, Dorval C, Martiat P, Lewalle P, Lagneaux L, Bron D.

Stem Cells Dev. 2009 Nov;18(9):1247-52. doi: 10.1089/scd.2009.0029.

PMID:
19309241
7.

An illustrated case of altered cellular immunity after autologous stem cell transplantation.

Hites M, Deweweire A, Crokaert F, Kornreich A, Kentos A.

Acta Clin Belg. 2007 Sep-Oct;62(5):300-3.

PMID:
18229462
8.

Real-time PCR for determining capsular serotypes of Haemophilus influenzae.

Maaroufi Y, De Bruyne JM, Heymans C, Crokaert F.

J Clin Microbiol. 2007 Jul;45(7):2305-8. Epub 2007 May 16.

9.

Development of a multiple internal control for clinical diagnostic real-time amplification assays.

Maaroufi Y, de Bruyne JM, Duchateau V, Scheen R, Crokaert F.

FEMS Immunol Med Microbiol. 2006 Nov;48(2):183-91.

10.

Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.

Viscoli C, Cometta A, Kern WV, Bock R, Paesmans M, Crokaert F, Glauser MP, Calandra T; International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer.

Clin Microbiol Infect. 2006 Mar;12(3):212-6.

11.
12.
13.

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.

Cometta A, Kern WV, De Bock R, Paesmans M, Vandenbergh M, Crokaert F, Engelhard D, Marchetti O, Akan H, Skoutelis A, Korten V, Vandercam M, Gaya H, Padmos A, Klastersky J, Zinner S, Glauser MP, Calandra T, Viscoli C; International Antimicrobial Therapy Group of the European Organization for Research Treatment of Cancer.

Clin Infect Dis. 2003 Aug 1;37(3):382-9. Epub 2003 Jul 22.

PMID:
12884163
14.

Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay.

Maaroufi Y, Heymans C, De Bruyne JM, Duchateau V, Rodriguez-Villalobos H, Aoun M, Crokaert F.

J Clin Microbiol. 2003 Jul;41(7):3293-8.

15.

Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.

Beguin Y, Benoit Y, Crokaert F, Selleslag D, Vandercam B; National Fund for Scientific Research.

Acta Clin Belg. 2002 Nov-Dec;57(6):309-16. Review.

16.

Disseminated infection due to Cylindrocarpon (Fusarium) lichenicola in a neutropenic patient with acute leukaemia: report of a case and review of the literature.

Rodríguez-Villalobos H, Georgala A, Beguin H, Heymans C, Pye G, Crokaert F, Aoun M.

Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):62-5. Epub 2003 Jan 18. Review.

PMID:
12582748
17.

Vibrio cholerae bacteremia in a neutropenic patient with non-small-cell lung carcinoma.

Berghmans T, Crokaert F, Sculier JP.

Eur J Clin Microbiol Infect Dis. 2002 Sep;21(9):676-8. Epub 2002 Sep 3. Review.

PMID:
12373501
18.

Cross reaction between a pan-Candida genus probe and Fusarium spp. in a fatal case of Fusarium oxysporum pneumonia.

Rodriguez-Villalobos H, Aoun M, Heymans C, De BJ, Duchateau V, Verdebout JM, Crokaert F.

Eur J Clin Microbiol Infect Dis. 2002 Feb;21(2):149-52. No abstract available.

PMID:
11939400
19.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases.

Clin Infect Dis. 2002 Jan 1;34(1):7-14. Epub 2001 Nov 26.

PMID:
11731939
20.

Pharmacodynamics, a tool for a better use of antibiotics?

Crokaert F.

Intensive Care Med. 2001 Feb;27(2):340-3. No abstract available.

PMID:
11396276
21.

[Infection and cancer: general information and specific questions].

Viot M, Blanc-Vincent MP, Béal J, Biron P, Boutard P, Malgrange VB, Crokaert F, Escande MC, Fuhrmann C, Lesimple T, Pény J, Pottecher B, Raveneau J, Senet JM, Thyss A.

Presse Med. 2000 Oct 7;29(29):1630-3. French.

PMID:
11072368
22.

Febrile neutropenia in children.

Crokaert F.

Int J Antimicrob Agents. 2000 Oct;16(2):173-6. Review.

PMID:
11053804
23.

[Standards, options and recommendations for good practice in hemoculture in cancerology].

Bussy Malgrange V, Blanc-Vincent MP, Escande MC, Fuhrmann C, Béal J, Boineau F, Biron P, Crokaert F, Lesimple T, Pottecher B, Raveneau J, Senet JM, Viot M.

Presse Med. 2000 Sep 23;29(27):1532-4. French.

PMID:
11045126
24.

[Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer].

Pottecher B, Herbrecht R, Blanc-Vincent MP, Bussy Malgrange V, Escande MC, Fuhrmann C, Crokaert F, Gory-Delabaere G, Senet JM, Lesimple T, Raveneau J, Béal J, Biron P, Viot M.

Bull Cancer. 2000 Jul;87(7-8):557-91. Review. French. Erratum in: Bull Cancer 2000 Sep;87(9):630.

25.

Imipenem versus targeted therapy in cancer patients.

Aoun M, Crokaert F, Paesmans M, Autier P, Klastersky J.

Int J Antimicrob Agents. 1998 Nov;10(4):263-70.

PMID:
9916899
26.

[Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer].

Biron P, Fuhrmann C, Escande MC, Blanc-Vincent MP, Crokaert F, Béal J, Bussy V, Lesimple T, Pottecher B, Raveneau J, Senet JM, Viot M.

Bull Cancer. 1998 Aug;85(8):695-711. French.

27.

Epidemiology of infections in the adult medical intensive care unit of a cancer hospital.

Berghmans T, Crokaert F, Markiewicz E, Sculier JP.

Support Care Cancer. 1997 May;5(3):234-40.

PMID:
9176971
28.

In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.

Crokaert F, Aoun M, Duchateau V, Grenier P, Vandermies A, Klastersky J.

Eur J Clin Microbiol Infect Dis. 1996 Aug;15(8):696-8. No abstract available.

PMID:
8894585
29.
31.
32.

Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.

Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E.

J Clin Microbiol. 1991 Sep;29(9):2072-5.

33.

Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1991;37(1):38-42.

PMID:
2013240
34.

Antibacterial effect of meropenem and imipenem on Proteus mirabilis.

Yourassowsky E, Van der Linden MP, Crokaert F.

J Antimicrob Chemother. 1990 Aug;26(2):185-92.

PMID:
2211455
35.

Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.

Yourassowsky E, van der Linden MP, Crokaert F.

Antimicrob Agents Chemother. 1990 Apr;34(4):505-9. Erratum in: Antimicrob Agents Chemother 1990 Aug;34(8):1622.

36.

Turbidimetric and microscopic analysis of Bacteroides fragilis exposed to tazobactam and piperacillin alone and in combination.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.

Chemotherapy. 1990;36(3):215-21.

PMID:
2159865
37.

One shot of high-dose amikacin: a working hypothesis.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1990;36(1):1-7.

PMID:
2106415
38.

Bactericidal activity of meropenem against Pseudomonas aeruginosa.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1989 Sep;24 Suppl A:169-74.

PMID:
2509414
39.

Growth Curve Patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris Submitted to Different Tigemonam Concentrations.

Yourassowsky E, Linden MP, Lismont MJ, Crokaert F.

J Chemother. 1989 May;1(sup2):49-53.

PMID:
27416151
40.

Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F.

J Chemother. 1989 May;1 Suppl 2:49-53.

PMID:
2681561
41.

Correlation between the growth and killing curves of Escherichia coli in the presence of cefotetan or piperacillin.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Chemotherapy. 1989;35(1):12-6.

PMID:
2656117
42.

Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1989;35(6):423-30.

PMID:
2515040
43.

Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Antimicrob Agents Chemother. 1988 Nov;32(11):1632-5.

44.

Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1988 Oct;22 Suppl D:43-7.

PMID:
3144548
45.

Determination of serum bactericidal activity against Escherichia coli by an automated photometric method.

Crokaert F, Lismont MJ, van der Linden MP, Yourassowsky E.

J Clin Microbiol. 1988 Oct;26(10):2069-76.

46.

Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):433-4. No abstract available.

PMID:
3137055
47.

Prolonged survival after resection of a malignant melanoma metastatic to the stomach.

Pector JC, Crokaert F, Lejeune F, Gerard A.

Cancer. 1988 May 15;61(10):2134-5. No abstract available.

PMID:
3359409
48.

Effect of antibiotics carry-over on bacterial counting by 'spiral plating'.

Yourassowsky E, Van der Linden MP, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1988 Jan;21(1):138-40. No abstract available. Erratum in: J Antimicrob Chemother 1988 Jun;21(6):813.

PMID:
3356621
49.

Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Chemotherapy. 1988;34(3):191-4.

PMID:
2843324
50.

Selection and counting of aerobic gram-negative bacilli in saliva by the spiral system.

Yourassowsky E, Van der Linden MP, Pardaens Y, Crokaert F, Glupczynski Y.

Eur J Clin Microbiol. 1987 Dec;6(6):634-6.

PMID:
3440455

Supplemental Content

Loading ...
Support Center